[
    "ide solution. In addition, sterile, fixed oils are conventionally employed as a solvent or suspending medium. For this purpose any bland fixed oil may be employed including synthetic mono- or diglycerides. In addition fatty acids such as oleic acid find use in the preparation of injectables. C) By inhalation, in the form of aerosols or solutions for nebulizers.</p>D) Rectally, in the form of suppositories prepared by mixing the drug with a suitable non-irritating excipient which is solid at ordinary temperature but liquid at the rectal temperature and will therefore melt in the rectum to release the drug. Such materials are cocoa butter and poly-ethylene glycols. E) Topically, in the form of creams, ointments, jellies, collyriums, solutions or suspesions.</p>The invention will be further described in the Examples which follow: EXAMPLES General Synthetic Procedures The following general schemes 1 to 10 are referred to in the Reference Examples as</p>Examples which follow:</p>Scheme 1</p></p>Conditions: (i) H<sub>2</sub>SO<sub>4</sub>, 21 h. (ii) Dioxane, DMF-DMA, 80<sup>0</sup>C, 24 h, 90\u00b0, 16 h. (iii) MeOH-THF Raney\u00ae Nickel, NH<sub>2</sub>NH<sub>2</sub>-H<sub>2</sub>O, RT, 40 min. (iv) DMSO, KOAc, Pd(dppf)<sub>2</sub>Cl<sub>2</sub> 80<sup>0</sup>C. \n\n Scheme 2</p></p>(vii)</p></p>Conditions: (i) DMF, TFAA, 0<sup>0</sup>C. (ii) 10% aq NaOH, 100<sup>0</sup>C, Ih. (iii) MeOH, H<sub>2</sub>SO<sub>4</sub>, 65\u00b0C, 18 h. (iv) Tl(OCOCFj)<sub>3</sub>, TFA, RT, 2 h. (v) H<sub>2</sub>O, KI, RT. (vi) MeOH, 40% aq NaOH, 65\u00b0C, 2 h. (vii) pinacol borane, Et<sub>3</sub>N, Dioxane, Pd(OAc)<sub>2</sub>, bis(cyclohexyl)phosphino-2-biphenyl, 80 <sup>0</sup>C, 30 min.</p>Scheme 3</p>A = N, B = CH B = N \n\n \n\n \n\n</p>Scheme 4</p></p>(iii)</p></p>Conditions: (i) morpholine, MeOH, RT, 12 h. (ii) DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, -78<sup>0</sup>C, 4 h. (iii) R1R2NH, Na(OAc)<sub>3</sub>BH, 1,2- DCE, (MeO)<sub>3</sub>CH or R1R2NH, MeOH, NaBH<sub>4</sub>. (iv) boronate ester, Suzuki coupling conditions.</p>Scheme 5</p></p>Conditions: (i) morpholine, Et<sub>3</sub>N, MeOH, 65\u00b0C, 18 h. (ii) isoamylnitrite, CH<sub>2</sub>I<sub>2</sub>, CuI, THF, 67\u00b0C, 1 h.</p>Scheme 6 \n\n \n\n</p>(IV)</p></p>Conditions: (i) Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, Zn, Zn(CN)<sub>2</sub>, DMA, 120<sup>0</sup>C, 45 min. (ii) HCl, MeOH, 65\u00b0C, 3 h. (iii) THF, EtOH, NaBH<sub>4</sub>, 0\u00b0C\u2192RT, 2 h. (iv) DCM, CBr<sub>4</sub>, PPh<sub>3</sub>, RT, 5 h. (v) R1R2NH, CH<sub>3</sub>CN, RT, 45 min. (vi) Suzuki coupling.</p>Scheme 7</p>\n Conditions: (i) morpholine, THF, DIPEA, 60\u00b0C, 18 h. (ii) Oxone\u00ae, Bu<sub>4</sub>NHSO<sub>4</sub>, DCM, RT, 18 h. (iii) boronate ester, PdCl<sub>2</sub>(PCy<sub>3</sub>)<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, microwave 125\u00b0C, 10 minutes, (iv) R1R2NH, DIPEA, microwave, 150<sup>0</sup>C, 30 min. \n\n Scheme 8</p></p>(iii)</p></p>Conditions: (i) PPh<sub>3</sub>, Toluene, 111\u00b0C, 2 h. (ii) ArCHO, Et<sub>3</sub>N, Toluene, 111\u00b0C, 24 h. (iii) Pd-C, H<sub>2</sub>, EtOH - AcOH, 2 "
]